Global Pharmaceutical Manufacturing Industry Market Outlook, 2031
The pharmaceutical manufacturing market is expanding with rising global demand for medicines and vaccines.
- Bonafide Trust
- 30-03-2026
- Pages : 228
- Figures : 10
- Tables : 142
- Region : Global
- Category : Lifescience & Healthcare
- Pharmaceutical
The pharmaceutical manufacturing industry market refers to the global sector engaged in the production, formulation, and distribution of medicinal drugs, biologics, and vaccines used to prevent, diagnose, and treat diseases. This market encompasses a wide range of products, including small-molecule drugs, active pharmaceutical ingredients (APIs), over the counter (OTC) medications, biosimilars, vaccines, nutraceuticals, and specialty pharmaceuticals. Pharmaceutical manufacturing involves complex processes such as chemical synthesis, fermentation, formulation, compounding, sterilization, quality control, packaging, and compliance with stringent regulatory standards. The industry is supported by a global ecosystem of raw material suppliers, contract manufacturing organizations (CMOs), research and development laboratories, regulatory agencies, distributors, and healthcare providers. Key drivers of the market include rising global healthcare demand, increasing prevalence of chronic and lifestyle diseases, aging populations, and advancements in biotechnology and drug development. Pharmaceutical manufacturing is highly regulated, with oversight from agencies such as the U.S. FDA, European Medicines Agency (EMA), and other national regulatory bodies, ensuring product safety, efficacy, and quality. Personalized medicine, targeted therapies, continuous manufacturing, and adoption of digital and automated production technologies are transforming the market. Advanced manufacturing techniques, including high-potency drug production, continuous flow chemistry, and process analytical technology (PAT), enhance operational efficiency, reduce production costs, and improve drug quality. The COVID-19 pandemic further highlighted the importance of agile pharmaceutical manufacturing capabilities, particularly for vaccine production and rapid drug development. Environmental sustainability and green manufacturing practices are also gaining focus, prompting companies to reduce waste, energy consumption, and carbon footprint.
The pharmaceutical manufacturing industry market is experiencing sustained growth driven by rising healthcare needs, technological innovation, and global expansion of drug production capabilities. Increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, oncology, and respiratory illnesses is a key factor driving demand for both generic and specialty drugs. The industry has witnessed significant investment in biopharmaceuticals, vaccines, and personalized medicine, enabling treatment of complex conditions with high efficacy. Contract manufacturing organizations (CMOs) are becoming increasingly integral, providing scalable, cost-efficient, and specialized production services, particularly for small and medium sized pharmaceutical companies that lack in house manufacturing facilities. Technological advancements are reshaping manufacturing processes, with digitalization, automation, and advanced analytics enhancing efficiency, traceability, and compliance. Continuous manufacturing, process analytical technology (PAT), and modular production facilities allow faster drug development, reduced production timelines, and consistent quality. High potency active pharmaceutical ingredient (API) production and formulation capabilities are expanding to meet demand for specialty drugs and biologics. Regulatory compliance remains a critical factor, with Good Manufacturing Practices (GMP), quality assurance protocols, and stringent validation standards governing production, packaging, and distribution. The market is also influenced by global supply chain dynamics, raw material availability, pricing fluctuations, and trade policies, affecting production costs and timelines. Geographically, demand for pharmaceutical manufacturing is expanding rapidly in Asia Pacific, driven by increasing local production, cost advantages, and growing domestic and export demand, while North America and Europe focus on advanced manufacturing technologies, R&D integration, and high value drug production. Sustainability initiatives, such as reducing carbon emissions, energy efficient production, and eco-friendly packaging, are becoming key differentiators. The pharmaceutical manufacturing industry market is poised for growth due to rising global healthcare needs, technological adoption, outsourcing of manufacturing operations, and expansion into emerging markets while maintaining stringent regulatory compliance and quality standards.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Dynamics
Market Drivers
• Rising Global Drug Demand Increasing prevalence of chronic diseases, aging populations, and growing healthcare access are driving demand for pharmaceutical products. Manufacturers are scaling production of generics, branded drugs, and specialty medicines to meet rising patient needs, ensuring consistent supply across hospitals, pharmacies, and retail channels worldwide.
• Technological Advancements Innovations in continuous manufacturing, high-throughput screening, automation, and biopharmaceutical production are enhancing efficiency, quality, and cost-effectiveness. Advanced formulation technologies, process optimization, and digital solutions improve scalability, reduce time-to-market, and support regulatory compliance, encouraging manufacturers to adopt modernized production systems globally.
Market Challenges
• Regulatory Complexity Pharmaceutical manufacturers face stringent compliance requirements from agencies such as the FDA, EMA, and WHO. Ensuring product safety, efficacy, and quality through clinical trials, documentation, and inspections increases costs and extends time-to-market, posing challenges for new entrants and smaller manufacturers.
• Supply Chain Vulnerabilities Dependence on raw materials like active pharmaceutical ingredients (APIs), intermediates, and excipients exposes manufacturers to supply disruptions. Geopolitical tensions, price volatility, and transportation delays impact production schedules and profitability, requiring resilient and diversified sourcing strategies.
Market Trends
• Continuous and Flexible Manufacturing Manufacturers are adopting continuous and modular production technologies to increase efficiency, reduce waste, and respond quickly to market demand fluctuations. This trend supports rapid scaling, personalized medicine production, and cost-effective operations across pharmaceutical segments.
• Biosimilars and Specialty Drugs The growth of biosimilars, targeted therapies, and high-value specialty drugs is reshaping the manufacturing landscape. Companies are investing in advanced bioprocessing, cell and gene therapy platforms, and precision formulation to meet regulatory standards and cater to emerging therapeutic needs, driving industry innovation.
Regional Analysis
The pharmaceutical manufacturing industry market exhibits notable regional variation based on regulatory frameworks, technological maturity, healthcare infrastructure, and production capacity. North America is a highly mature market, led by the United States, which is home to major pharmaceutical manufacturers, advanced biopharmaceutical R&D facilities, and strict regulatory oversight by the FDA. The region emphasizes high quality production, biologics, specialty drugs, and complex formulations, while leveraging automation, AI, and digital manufacturing technologies for operational efficiency. Europe also represents a well-established market, with Germany, Switzerland, France, and the United Kingdom leading in advanced drug production, particularly in biotechnology, vaccines, and specialty pharmaceuticals. Regulatory compliance with EMA standards, stringent GMP adherence, and innovation driven production are defining features of the European market. Asia Pacific is the fastest-growing region, driven by India, China, Japan, and South Korea, which provide large-scale production capacities, cost effective manufacturing, and increasing domestic and export demand. India is a global hub for generic drugs and APIs, while China is a leader in API production, formulation, and vaccine manufacturing. Southeast Asian countries such as Thailand, Malaysia, and Vietnam are witnessing accelerated growth due to investment in pharmaceutical infrastructure and favorable government policies. Latin America shows moderate growth, with Brazil and Mexico contributing through local production of generics, vaccines, and essential medicines, supported by increasing healthcare investment. The Middle East and Africa are emerging markets, with expansion driven by rising healthcare access, government-led initiatives, and establishment of pharmaceutical manufacturing units in the UAE, Saudi Arabia, and South Africa. Across all regions, factors such as regulatory compliance, technology adoption, supply chain efficiency, and R&D capabilities determine market competitiveness, while Asia Pacific leads in production volume and cost advantages, and North America and Europe focus on high-value, innovative, and complex drug manufacturing.
Key Developments
• 2025 – Pfizer expanded its global manufacturing footprint for mRNA-based vaccines and specialty therapeutics with new facilities in Asia and Europe.
• 2025 – Novartis invested in continuous manufacturing and automation technologies to improve production efficiency, reduce costs, and enhance quality control.
• 2024 – Cipla scaled up API and generic drug production in India to support global export demand and meet regulatory compliance standards.
• 2024 – Roche launched advanced biologics and personalized medicine manufacturing lines in Europe, integrating AI-based process monitoring.
• 2023 – Samsung Biologics expanded contract manufacturing capabilities for monoclonal antibodies and vaccines, catering to global pharmaceutical clients.
Table of Contents
- 1 Introduction 13 1.1 Industry Definition And Research Scope 13 1.1.1 Industry Definition 13 1.1.2 Research Scope 14 1.2 Research Methodology 17 1.2.1 Overview Of Market Research Methodology 17 1.2.2 Market Assumption 18 1.2.3 Secondary Data 18 1.2.4 Primary Data 18 1.2.5 Data Filtration And Model Design 19 1.2.6 Market Size/Share Estimation 20 1.2.7 Research Limitations 21 1.3 Executive Summary 22 2 Market Overview And Dynamics 25 2.1 Market Size And Forecast 25 2.1.1 Impact Of Covid-19 On World Economy 28 2.1.2 Impact Of Covid-19 On The Market 31 2.1.3 Impact Of Russia-Ukraine Conflict: War Slows Economic Recovery 33 2.2 Major Growth Drivers 37 2.3 Market Restraints And Challenges 44 2.4 Emerging Opportunities And Market Trends 47 2.5 Porter’S Fiver Forces Analysis 51 3 Segmentation Of Global Market By Formulation 55 3.1 Market Overview By Formulation 55 3.2 Tablets 57 3.3 Capsules 58 3.4 Injectable 59 3.5 Sprays 60 3.6 Suspensions 61 3.7 Powders 62 3.8 Other Formulations 63 4 Segmentation Of Global Market By Route Of Administration 64 4.1 Market Overview By Route Of Administration 64 4.2 Oral Medicine 66 4.3 Topical Medicine 67 4.4 Parenteral Medicine 68 4.5 Inhalations 69 4.6 Other Routes Of Administration 70 5 Segmentation Of Global Market By Consumer Group 71 5.1 Market Overview By Consumer Group 71 5.2 Children & Adolescents (17 Years Old And Below) 73 5.3 Adults (18-64 Years Old) 74 5.4 Geriatric (65 Years Old And Above) 75 6 Segmentation Of Global Market By Therapeutic Application 76 6.1 Market Overview By Therapeutic Application 76 6.2 Cardiovascular Diseases 78 6.3 Pain 79 6.4 Diabetes 80 6.5 Cancer 81 6.6 Respiratory Diseases 82 6.7 Neurological Diseases 83 6.8 Orthopedics 84 6.9 Other Applications 85 7 Segmentation Of Global Market By Drug Type 86 7.1 Market Overview By Drug Type 86 7.2 Branded Prescription Drugs 88 7.3 Generic Prescription Drugs 89 7.4 Otc Drugs 90 8 Segmentation Of Global Market By Distribution Channel 91 8.1 Market Overview By Distribution Channel 91 8.2 Retail Channels 93 8.3 Non-Retail Channels 94 9 Segmentation Of Global Market By Manufacturing Facility 95 9.1 Market Overview By Manufacturing Facility 95 9.2 In-House Facility 97 9.3 Outsourced Facility 98 10 Segmentation Of Global Market By Region 99 10.1 Geographic Market Overview 2022-2032 99 10.2 North America Market 2022-2032 By Country 103 10.2.1 Overview Of North America Market 103 10.2.2 U.S. 107 10.2.3 Canada 114 10.2.4 Mexico 116 10.3 European Market 2022-2032 By Country 118 10.3.1 Overview Of European Market 118 10.3.2 Germany 122 10.3.3 U.K. 124 10.3.4 France 126 10.3.5 Spain 128 10.3.6 Italy 130 10.3.7 Netherlands 132 10.3.8 Rest Of European Market 134 10.4 Asia-Pacific Market 2022-2032 By Country 136 10.4.1 Overview Of Asia-Pacific Market 136 10.4.2 Japan 140 10.4.3 China 143 10.4.4 Australia 145 10.4.5 India 147 10.4.6 South Korea 149 10.4.7 Rest Of Apac Region 151 10.5 South America Market 2022-2032 By Country 153 10.5.1 Argentina 156 10.5.2 Brazil 158 10.5.3 Chile 160 10.5.4 Rest Of South America Market 162 10.6 Mea Market 2022-2032 By Country 163 10.6.1 Uae 166 10.6.2 Saudi Arabia 168 10.6.3 South Africa 170 10.6.4 Other National Markets 172 11 Competitive Landscape 173 11.1 Overview Of Key Vendors 173 11.2 New Product Launch, Partnership, Investment, And M&A 176 11.3 Company Profiles 177 Abbott Laboratories 177 Aenova Group 179 Amgen Inc. 183 Astrazeneca 186 Catalent Inc. 189 Eli Lilly And Company 192 F. Hoffmann-La Roche Ltd. 194 Gilead Sciences Inc. 196 Glaxosmithkline Plc 198 Johnson & Johnson 202 Lonza Group 204 Lupin Limited 207 Merck & Co., Inc. 209 Novartis Ag 211 Novo Nordisk 213 Patheon Inc. 216 Pfizer Centresource 220 Sanofi Sa 224 Takeda 226 Related Reports 228
Table 1. Snapshot Of Global Pharmaceutical Manufacturing Industry In Balanced Perspective, 2022-2032 23 Table 2. World Pharmaceuticals Output By Region, 2022-2025, Annual Percentage Change 27 Table 3. World Economic Outlook, 2021-2031 29 Table 4. World Economic Outlook, 2021-2023 30 Table 5. Scenarios For Economic Impact Of Ukraine Crisis 34 Table 6. World Health Spending By Region, $ Bn, 2013-2020 43 Table 7. Main Product Trends And Market Opportunities In Global Pharmaceutical Manufacturing Industry 47 Table 8. Global Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 55 Table 9. Global Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 64 Table 10. Global Pharmaceutical Manufacturing Industry By Consumer Group, 2022-2032, $ Mn 71 Table 11. Global Pharmaceutical Manufacturing Industry By Therapeutic Application, 2022-2032, $ Mn 76 Table 12. Global Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 86 Table 13. Global Pharmaceutical Manufacturing Industry By Distribution Channel, 2022-2032, $ Mn 91 Table 14. Global Pharmaceutical Manufacturing Industry By Manufacturing Facility, 2022-2032, $ Mn 95 Table 15. Global Pharmaceutical Manufacturing Industry By Region, 2022-2032, $ Mn 100 Table 16. Leading National Pharmaceutical Manufacturing Industry, 2022 And 2032, $ Mn 102 Table 17. North America Pharmaceutical Manufacturing Industry By Country, 2022-2032, $ Mn 105 Table 18. U.S. Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 109 Table 19. U.S. Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 109 Table 20. U.S. Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 109 Table 21. Canada Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 115 Table 22. Canada Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 115 Table 23. Canada Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 115 Table 24. Mexico Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 117 Table 25. Mexico Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 117 Table 26. Mexico Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 117 Table 27. Europe Pharmaceutical Manufacturing Industry By Country, 2022-2032, $ Mn 121 Table 28. Germany Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 123 Table 29. Germany Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 123 Table 30. Germany Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 123 Table 31. U.K. Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 125 Table 32. U.K. Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 125 Table 33. U.K. Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 125 Table 34. France Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 127 Table 35. France Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 127 Table 36. France Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 127 Table 37. Spain Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 129 Table 38. Spain Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 129 Table 39. Spain Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 129 Table 40. Italy Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 131 Table 41. Italy Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 131 Table 42. Italy Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 131 Table 43. Netherlands Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 133 Table 44. Netherlands Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 133 Table 45. Netherlands Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 133 Table 46. Pharmaceutical Manufacturing Industry In Rest Of Europe By Country, 2022-2032, $ Mn 135 Table 47. Apac Pharmaceutical Manufacturing Industry By Country, 2022-2032, $ Mn 138 Table 48. Japan Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 142 Table 49. Japan Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 142 Table 50. Japan Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 142 Table 51. China Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 144 Table 52. China Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 144 Table 53. China Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 144 Table 54. Australia Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 146 Table 55. Australia Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 146 Table 56. Australia Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 146 Table 57. India Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 148 Table 58. India Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 148 Table 59. India Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 148 Table 60. South Korea Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 150 Table 61. South Korea Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 150 Table 62. South Korea Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 150 Table 63. Pharmaceutical Manufacturing Industry In Rest Of Apac By Country/Region, 2022-2032, $ Mn 152 Table 64. South America Pharmaceutical Manufacturing Industry By Country, 2022-2032, $ Mn 155 Table 65. Argentina Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 157 Table 66. Argentina Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 157 Table 67. Argentina Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 157 Table 68. Brazil Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 159 Table 69. Brazil Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 159 Table 70. Brazil Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 159 Table 71. Chile Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 161 Table 72. Chile Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 161 Table 73. Chile Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 161 Table 74. Mea Pharmaceutical Manufacturing Industry By Country, 2022-2032, $ Mn 165 Table 75. Uae Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 167 Table 76. Uae Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 167 Table 77. Uae Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 167 Table 78. Saudi Arabia Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 169 Table 79. Saudi Arabia Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 169 Table 80. Saudi Arabia Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 169 Table 81. South Africa Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, $ Mn 171 Table 82. South Africa Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, $ Mn 171 Table 83. South Africa Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, $ Mn 171 Table 84. Abbott Laboratories: Company Snapshot 177 Table 85. Abbott Laboratories: Business Segmentation 178 Table 86. Abbott Laboratories: Product Portfolio 178 Table 87. Aenova Group: Company Snapshot 179 Table 88. Aenova Group: Business Segmentation 180 Table 89. Aenova Group: Revenue By Product, 2018-2019, Thousand Euro 181 Table 90. Aenova Group: Recent Developments 182 Table 91. Amgen Inc.: Company Snapshot 183 Table 92. Amgen Inc.: Approved Drugs Or Therapeutic Biologicals 184 Table 93. Astrazeneca: Company Snapshot 186 Table 94. Catalent Inc.: Company Snapshot 189 Table 95. Catalent Inc.: Business Segmentation In 2018 190 Table 96. Catalent Inc.: Product Portfolio 190 Table 97. Catalent Inc.: Revenue, 2018-2020, $ Million 191 Table 98. Catalent Inc.: Revenue By Region In 2018 191 Table 99. Eli Lilly And Company: Company Snapshot 192 Table 100. Eli Lilly And Company: Pharmaceutical Brands 193 Table 101. F. Hoffmann-La Roche: Company Snapshot 194 Table 102. F. Hoffmann-La Roche: Business Segmentation 194 Table 103. F. Hoffmann-La Roche: Revenue, 2017-2019, $ Bn 195 Table 104. Gilead Sciences: Company Snapshot 196 Table 105. Gilead Sciences: Main Products 196 Table 106. Glaxosmithkline: Company Snapshot 198 Table 107. Glaxosmithkline: Business Segmentation 199 Table 108. Glaxosmithkline: Product Portfolio 200 Table 109. Glaxosmithkline: Revenue, 2018-2020, $ Bn 201 Table 110. Johnson & Johnson: Company Snapshot 202 Table 111. Johnson & Johnson: Business Segments 202 Table 112. Lonza Group: Company Snapshot 204 Table 113. Lonza Group: Business Segmentation In 2018 204 Table 114. Lonza Group: Product Portfolio 205 Table 115. Lonza Group: Revenue By Region In 2018 205 Table 116. Lupin Limited: Company Snapshot 207 Table 117. Lupin Limited: Business Segmentation 208 Table 118. Merck & Co., Inc.: Company Snapshot 209 Table 119. Merck & Co., Inc.: Business Segmentation 209 Table 120. Merck & Co., Inc.: Revenue, 2018-2020, $ Bn 210 Table 121. Novartis International Ag: Company Snapshot 211 Table 122. Novartis International Ag: Business Segmentation 211 Table 123. Novartis International Ag: Revenue, 2017-2019, $ Bn 212 Table 124. Novo Nordisk: Company Snapshot 213 Table 125. Novo Nordisk: Product Portfolio 214 Table 126. Patheon Inc.: Company Snapshot 216 Table 127. Patheon Inc.: Business Segmentation In 2018 217 Table 128. Patheon Inc.: Product Portfolio 217 Table 129. Patheon Inc.: Revenue, 2017-2019, $ Billion 218 Table 130. Patheon Inc.: Revenue By Region In 2018 218 Table 131. Patheon Inc.: Recent Developments 219 Table 132. Pfizer Centresource: Company Snapshot 220 Table 133. Pfizer Centresource: Business Segmentation In 2018 221 Table 134. Pfizer Centresource: Product Portfolio 221 Table 135. Pfizer Centresource: Revenue, 2017-2019, $ Billion 222 Table 136. Pfizer Centresource: Revenue By Region In 2018 222 Table 137. Hospira, Inc. (A Subsidiary Of Pfizer): Company Snapshot 222 Table 138. Pfizer Centresource: Recent Developments 223 Table 139. Sanofi: Company Snapshot 224 Table 140. Sanofi: Business Segmentation 224 Table 141. Sanofi: Revenue, 2018-2020, $ Bn 225 Table 142. Takeda Pharmaceutical Co. Ltd.: Company Snapshot 226
Figure 1. Research Method Flow Chart 17 Figure 2. Bottom-Up Approach And Top-Down Approach For Market Estimation 20 Figure 3. Global Market Forecast In Optimistic, Conservative And Balanced Perspectives, 2022-2032 22 Figure 4. Global Pharmaceutical Manufacturing Industry, 2022-2032, $ Mn 25 Figure 5. World Healthcare Services Production, Annual Percentage Change 27 Figure 6. Impact Of Covid-19 On Business 31 Figure 7. Primary Drivers And Impact Factors Of Global Pharmaceutical Manufacturing Industry 37 Figure 8. Trends In The Approval Of Cancer Therapies By Fda In The Twenty-First Century 40 Figure 9. Leading Causes Of Death In The World, 2000 And 2019, Million 41 Figure 10. Worldwide Geriatric Population (60 Years And Above) By Region, 2015 & 2030, Million 42 Figure 11. World Population 65 And Over, % Of Total Population, 1950-2060 42 Figure 12. Primary Restraints And Impact Factors Of Global Pharmaceutical Manufacturing Industry 44 Figure 13. Investment Opportunity Analysis 48 Figure 14. Porter’S Fiver Forces Analysis Of Global Pharmaceutical Manufacturing Industry 51 Figure 15. Breakdown Of Global Pharmaceutical Manufacturing Industry By Formulation, 2022-2032, % Of Revenue 56 Figure 16. Global Addressable Market Cap In 2023-2032 By Formulation, Value ($ Mn) And Share (%) 56 Figure 17. Global Pharmaceutical Manufacturing Industry By Formulation: Tablets, 2022-2032, $ Mn 57 Figure 18. Global Pharmaceutical Manufacturing Industry By Formulation: Capsules, 2022-2032, $ Mn 58 Figure 19. Global Pharmaceutical Manufacturing Industry By Formulation: Injectable, 2022-2032, $ Mn 59 Figure 20. Global Pharmaceutical Manufacturing Industry By Formulation: Sprays, 2022-2032, $ Mn 60 Figure 21. Global Pharmaceutical Manufacturing Industry By Formulation: Suspensions, 2022-2032, $ Mn 61 Figure 22. Global Pharmaceutical Manufacturing Industry By Formulation: Powders, 2022-2032, $ Mn 62 Figure 23. Global Pharmaceutical Manufacturing Industry By Formulation: Other Formulations, 2022-2032, $ Mn 63 Figure 24. Breakdown Of Global Pharmaceutical Manufacturing Industry By Route Of Administration, 2022-2032, % Of Sales Revenue 65 Figure 25. Global Addressable Market Cap In 2023-2032 By Route Of Administration, Value ($ Mn) And Share (%) 65 Figure 26. Global Pharmaceutical Manufacturing Industry By Route Of Administration: Oral Medicine, 2022-2032, $ Mn 66 Figure 27. Global Pharmaceutical Manufacturing Industry By Route Of Administration: Topical Medicine, 2022-2032, $ Mn 67 Figure 28. Global Pharmaceutical Manufacturing Industry By Route Of Administration: Parenteral Medicine, 2022-2032, $ Mn 68 Figure 29. Global Pharmaceutical Manufacturing Industry By Route Of Administration: Inhalations, 2022-2032, $ Mn 69 Figure 30. Global Pharmaceutical Manufacturing Industry By Route Of Administration: Other Routes Of Administration, 2022-2032, $ Mn 70 Figure 31. Breakdown Of Global Pharmaceutical Manufacturing Industry By Consumer Group, 2022-2032, % Of Sales Revenue 72 Figure 32. Global Addressable Market Cap In 2023-2032 By Consumer Group, Value ($ Mn) And Share (%) 72 Figure 33. Global Pharmaceutical Manufacturing Industry By Consumer Group: Children & Adolescents (17 Years Old And Below), 2022-2032, $ Mn 73 Figure 34. Global Pharmaceutical Manufacturing Industry By Consumer Group: Adults (18-64 Years Old), 2022-2032, $ Mn 74 Figure 35. Global Pharmaceutical Manufacturing Industry By Consumer Group: Geriatric (65 Years Old And Above), 2022-2032, $ Mn 75 Figure 36. Breakdown Of Global Pharmaceutical Manufacturing Industry By Therapeutic Application, 2022-2032, % Of Revenue 77 Figure 37. Global Addressable Market Cap In 2023-2032 By Therapeutic Application, Value ($ Mn) And Share (%) 77 Figure 38. Global Pharmaceutical Manufacturing Industry By Therapeutic Application: Cardiovascular Diseases, 2022-2032, $ Mn 78 Figure 39. Global Pharmaceutical Manufacturing Industry By Therapeutic Application: Pain, 2022-2032, $ Mn 79 Figure 40. Global Pharmaceutical Manufacturing Industry By Therapeutic Application: Diabetes, 2022-2032, $ Mn 80 Figure 41. Global Pharmaceutical Manufacturing Industry By Therapeutic Application: Cancer, 2022-2032, $ Mn 81 Figure 42. Global Pharmaceutical Manufacturing Industry By Therapeutic Application: Respiratory Diseases, 2022-2032, $ Mn 82 Figure 43. Global Pharmaceutical Manufacturing Industry By Therapeutic Application: Neurological Diseases, 2022-2032, $ Mn 83 Figure 44. Global Pharmaceutical Manufacturing Industry By Therapeutic Application: Orthopedics, 2022-2032, $ Mn 84 Figure 45. Global Pharmaceutical Manufacturing Industry By Therapeutic Application: Other Applications, 2022-2032, $ Mn 85 Figure 46. Breakdown Of Global Pharmaceutical Manufacturing Industry By Drug Type, 2022-2032, % Of Revenue 87 Figure 47. Global Addressable Market Cap In 2023-2032 By Drug Type, Value ($ Mn) And Share (%) 87 Figure 48. Global Pharmaceutical Manufacturing Industry By Drug Type: Branded Prescription Drugs, 2022-2032, $ Mn 88 Figure 49. Global Pharmaceutical Manufacturing Industry By Drug Type: Generic Prescription Drugs, 2022-2032, $ Mn 89 Figure 50. Global Pharmaceutical Manufacturing Industry By Drug Type: Otc Drugs, 2022-2032, $ Mn 90 Figure 51. Breakdown Of Global Pharmaceutical Manufacturing Industry By Distribution Channel, 2022-2032, % Of Revenue 91 Figure 52. Global Addressable Market Cap In 2023-2032 By Distribution Channel, Value ($ Mn) And Share (%) 92 Figure 53. Global Pharmaceutical Manufacturing Industry By Distribution Channel: Retail Channels, 2022-2032, $ Mn 93 Figure 54. Global Pharmaceutical Manufacturing Industry By Distribution Channel: Non-Retail Channels, 2022-2032, $ Mn 94 Figure 55. Breakdown Of Global Pharmaceutical Manufacturing Industry By Manufacturing Facility, 2022-2032, % Of Revenue 95 Figure 56. Global Addressable Market Cap In 2023-2032 By Manufacturing Facility, Value ($ Mn) And Share (%) 96 Figure 57. Global Pharmaceutical Manufacturing Industry By Manufacturing Facility: In-House Facility, 2022-2032, $ Mn 97 Figure 58. Global Pharmaceutical Manufacturing Industry By Manufacturing Facility: Outsourced Facility, 2022-2032, $ Mn 98 Figure 59. Global Market Snapshot By Region 99 Figure 60. Geographic Spread Of Worldwide Pharmaceutical Manufacturing Industry, 2022-2032, % Of Sales Revenue 100 Figure 61. Global Addressable Market Cap In 2023-2032 By Region, Value ($ Mn) And Share (%) 101 Figure 62. North American Pharmaceutical Manufacturing Industry, 2022-2032, $ Mn 104 Figure 63. Breakdown Of North America Pharmaceutical Manufacturing Industry By Country, 2022 And 2032, % Of Revenue 105 Figure 64. Contribution To North America 2023-2032 Cumulative Market By Country, Value ($ Mn) And Share (%) 106 Figure 65. U.S. Pharmaceutical Manufacturing Industry, 2022-2032, $ Mn 108 Figure 66. Sources Of Api Manufacturing By Product Area In U.S., As Of May 2021 110 Figure 67. Manufacturing Locations Of Essential Medicines In U.S., As Of May 2021 111 Figure 68. Count Of High-Capacity Api Sites In U.S. In 2021 112 Figure 69. Fda-Approved Api Manufacturing Sites In U.S., 2016-2021 113 Figure 70. Canada Pharmaceutical Manufacturing Industry, 2022-2032, $ Mn 114 Figure 71. Pharmaceutical Manufacturing Industry In Mexico, 2022-2032, $ Mn 116 Figure 72. European Pharmaceutical Manufacturing Industry, 2022-2032, $ Mn 119 Figure 73. Breakdown Of European Pharmaceutical Manufacturing Industry By Country, 2022 And 2032, % Of Revenue 120 Figure 74. Contribution To Europe 2023-2032 Cumulative Market By Country, Value ($ Mn) And Share (%) 121 Figure 75. Pharmaceutical Manufacturing Industry In Germany, 2022-2032, $ Mn 122 Figure 76. Pharmaceutical Manufacturing Industry In U.K., 2022-2032, $ Mn 124 Figure 77. Pharmaceutical Manufacturing Industry In France, 2022-2032, $ Mn 126 Figure 78. Pharmaceutical Manufacturing Industry In Spain, 2022-2032, $ Mn 128 Figure 79. Pharmaceutical Manufacturing Industry In Italy, 2022-2032, $ Mn 130 Figure 80. Pharmaceutical Manufacturing Industry In Netherlands, 2022-2032, $ Mn 132 Figure 81. Pharmaceutical Manufacturing Industry In Rest Of Europe, 2022-2032, $ Mn 134 Figure 82. Asia-Pacific Pharmaceutical Manufacturing Industry, 2022-2032, $ Mn 137 Figure 83. Breakdown Of Apac Pharmaceutical Manufacturing Industry By Country, 2022 And 2032, % Of Revenue 137 Figure 84. Contribution To Apac 2023-2032 Cumulative Market By Country, Value ($ Mn) And Share (%) 139 Figure 85. Pharmaceutical Manufacturing Industry In Japan, 2022-2032, $ Mn 141 Figure 86. Pharmaceutical Manufacturing Industry In China, 2022-2032, $ Mn 143 Figure 87. Pharmaceutical Manufacturing Industry In Australia, 2022-2032, $ Mn 145 Figure 88. Pharmaceutical Manufacturing Industry In India, 2022-2032, $ Mn 147 Figure 89. Pharmaceutical Manufacturing Industry In South Korea, 2022-2032, $ Mn 149 Figure 90. Pharmaceutical Manufacturing Industry In Rest Of Apac, 2022-2032, $ Mn 151 Figure 91. South America Pharmaceutical Manufacturing Industry, 2022-2032, $ Mn 154 Figure 92. Breakdown Of South America Pharmaceutical Manufacturing Industry By Country, 2022 And 2032, % Of Revenue 154 Figure 93. Contribution To South America 2023-2032 Cumulative Market By Country, Value ($ Mn) And Share (%) 155 Figure 94. Pharmaceutical Manufacturing Industry In Argentina, 2022-2032, $ Mn 156 Figure 95. Pharmaceutical Manufacturing Industry In Brazil, 2022-2032, $ Mn 158 Figure 96. Pharmaceutical Manufacturing Industry In Chile, 2022-2032, $ Mn 160 Figure 97. Pharmaceutical Manufacturing Industry In Rest Of South America, 2022-2032, $ Mn 162 Figure 98. Pharmaceutical Manufacturing Industry In Middle East And Africa (Mea), 2022-2032, $ Mn 164 Figure 99. Breakdown Of Mea Pharmaceutical Manufacturing Industry By Country, 2022 And 2032, % Of Revenue 164 Figure 100. Contribution To Mea 2023-2032 Cumulative Market By Country, Value ($ Mn) And Share (%) 165 Figure 101. Pharmaceutical Manufacturing Industry In Uae, 2022-2032, $ Mn 166 Figure 102. Pharmaceutical Manufacturing Industry In Saudi Arabia, 2022-2032, $ Mn 168 Figure 103. Pharmaceutical Manufacturing Industry In South Africa, 2022-2032, $ Mn 170 Figure 104. Growth Stage Of Global 3D Printing Industry Over The Forecast Period 173 Figure 105. Top Products Of Astrazeneca Based On Revenue From 2016 To 2019 (In Million U.S. Dollars) 187
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (09 May, 2026)
- Notify To Team (09 May, 2026)
- Report updation (10 May, 2026)
- Report Quality Check (10 May, 2026)
- Report Dispatch (11 May, 2026)
- Hard Copy
Recently Viewed Products
Global Pharmaceutical Manufacturing Industry Market Outlook, 2031
We are friendly and approachable, give us a call.